1. Zhang, Jian, Zhou, Yiping, Zhang, Bo, Chen, Baofu, Ma, Haitao. . Bioinformatics analysis identifying FBXO45 gene as a potential oncogene in esophageal cancer. In Journal of gastrointestinal oncology, 12, 2653-2664. doi:10.21037/jgo-21-662. https://pubmed.ncbi.nlm.nih.gov/35070395/
2. Lin, Xiao-Tong, Yu, Hong-Qiang, Fang, Lei, Xiong, Hao-Jun, Xie, Chuan-Ming. 2021. Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation. In eLife, 10, . doi:10.7554/eLife.70715. https://pubmed.ncbi.nlm.nih.gov/34779401/
3. Zheng, Mengmeng, Wu, Linfeng, Xiao, Rongyao, Chen, Weike, Shen, Shurong. 2024. Fbxo45 facilitates the malignant progression of breast cancer by targeting Bim for ubiquitination and degradation. In BMC cancer, 24, 619. doi:10.1186/s12885-024-12382-8. https://pubmed.ncbi.nlm.nih.gov/38773471/
4. Wang, Kai, Qu, Xiao, Liu, Shaorui, Huang, Cuicui, Du, Jiajun. 2018. Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma. In Journal of cancer research and clinical oncology, 144, 1509-1521. doi:10.1007/s00432-018-2653-1. https://pubmed.ncbi.nlm.nih.gov/29728763/
5. von Danwitz, Marthe, Klümper, Niklas, Bernhardt, Marit, Ellinger, Jörg, Stein, Johannes. 2023. Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers. In Cancers, 15, . doi:10.3390/cancers15061890. https://pubmed.ncbi.nlm.nih.gov/36980776/